✦ LIBER ✦

Safety pharmacology in pharmaceutical development and approval

✍ Scribed by Per Spindler

Book ID: 114384712
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 40 KB
Volume: 9
Category: Article
ISSN: 1359-6446
DOI: 10.1016/s1359-6446(04)03070-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Approval times and the safety of new pha

Approval times and the safety of new pharmaceuticals

✍ Niklas Rudholm 📂 Article 📅 2004 🏛 Springer 🌐 French ⚖ 245 KB

Safety pharmacology and biopharmaceutica

Safety pharmacology and biopharmaceutical development

✍ Mark Maginn 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Manufacturing of Pharmaceutical Proteins

Manufacturing of Pharmaceutical Proteins || Pharmacology and Drug Safety

✍ Behme, Stefan 📂 Article 📅 2009 🏛 Wiley-VCH Verlag GmbH & Co. KGaA 🌐 German ⚖ 226 KB

Risk-benefit evaluation ## Clinical development determines the speed of product development Manufacturing process should be fixed before phase III j139

Safety pharmacology requirements for the

Safety pharmacology requirements for the development of human cardiac/cardiovascular pharmaceuticals

✍ Ian Mackenzie 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 1 views

Status of safety pharmacology in the pha

Status of safety pharmacology in the pharmaceutical industry, 1993

✍ Lewis B. Kinter; Kent A. Gossett; William D. Kerns 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 681 KB

Status of safety pharmacology in the pha

Status of safety pharmacology in the pharmaceutical industry—1995

✍ Andrew T. Sullivan; Lewis B. Kinter 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 1 views